WNT Signaling in Bone Homeostasis and Disease: from Human Mutations to Treatments

Overview

Journal Nat Med

Specialties General Medicine
Molecular Biology

Date 2013 Feb 8

PMID 23389618

Citations 922

Authors

Roland Baron

Michaela Kneissel

Affiliations

Soon will be listed here.

Abstract

Low bone mass and strength lead to fragility fractures, for example, in elderly individuals affected by osteoporosis or children with osteogenesis imperfecta. A decade ago, rare human mutations affecting bone negatively (osteoporosis-pseudoglioma syndrome) or positively (high-bone mass phenotype, sclerosteosis and Van Buchem disease) have been identified and found to all reside in components of the canonical WNT signaling machinery. Mouse genetics confirmed the importance of canonical Wnt signaling in the regulation of bone homeostasis, with activation of the pathway leading to increased, and inhibition leading to decreased, bone mass and strength. The importance of WNT signaling for bone has also been highlighted since then in the general population in numerous genome-wide association studies. The pathway is now the target for therapeutic intervention to restore bone strength in millions of patients at risk for fracture. This paper reviews our current understanding of the mechanisms by which WNT signalng regulates bone homeostasis.

Citing Articles

Bone and muscle crosstalk in ageing and disease.

Kirk B, Lombardi G, Duque G Nat Rev Endocrinol. 2025; .

PMID: 40011751 DOI: 10.1038/s41574-025-01088-x.

Correlation between uric acid levels and bone mineral density in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Zhao H, Qi C, Zhang Y, Ren L, Chen S Front Endocrinol (Lausanne). 2025; 16:1415550.

PMID: 39991737 PMC: 11842257. DOI: 10.3389/fendo.2025.1415550.

Synthetic Nanopillars for Stimulating Osteoblast Activity and Osteointegration in Bone-Related Disorders.

Liang W, Zhou C, Liu X, Xie Q, Xia L, Li Q Int J Nanomedicine. 2025; 20:2205-2223.

PMID: 39990287 PMC: 11847438. DOI: 10.2147/IJN.S501963.

Signaling Pathways Driving MSC Osteogenesis: Mechanisms, Regulation, and Translational Applications.

Wang L, Ruan M, Bu Q, Zhao C Int J Mol Sci. 2025; 26(3).

PMID: 39941080 PMC: 11818554. DOI: 10.3390/ijms26031311.

Methylase METTL3 regulates oxidative stress-induced osteoblast apoptosis through Wnt/β-catenin signaling pathway.

Yang P, Wang H, Meng L, Kou Y, Bu J, Li M J Mol Histol. 2025; 56(2):86.

PMID: 39928245 DOI: 10.1007/s10735-025-10358-x.

References

McClung M, San Martin J, Miller P, Civitelli R, Bandeira F, Omizo M . Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005; 165(15):1762-8. DOI: 10.1001/archinte.165.15.1762. View

Gaur T, Wixted J, Hussain S, OConnell S, Morgan E, Ayers D . Secreted frizzled related protein 1 is a target to improve fracture healing. J Cell Physiol. 2009; 220(1):174-81. PMC: 2756719. DOI: 10.1002/jcp.21747. View

Robling A, Kedlaya R, Ellis S, Childress P, Bidwell J, Bellido T . Anabolic and catabolic regimens of human parathyroid hormone 1-34 elicit bone- and envelope-specific attenuation of skeletal effects in Sost-deficient mice. Endocrinology. 2011; 152(8):2963-75. PMC: 3138236. DOI: 10.1210/en.2011-0049. View

Baron R, Ferrari S, Russell R . Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 2010; 48(4):677-92. DOI: 10.1016/j.bone.2010.11.020. View

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

Hoeppner L, Secreto F, Razidlo D, Whitney T, Westendorf J . Lef1DeltaN binds beta-catenin and increases osteoblast activity and trabecular bone mass. J Biol Chem. 2011; 286(13):10950-9. PMC: 3064150. DOI: 10.1074/jbc.M110.165100. View

Saxon L, Jackson B, Sugiyama T, Lanyon L, Price J . Analysis of multiple bone responses to graded strains above functional levels, and to disuse, in mice in vivo show that the human Lrp5 G171V High Bone Mass mutation increases the osteogenic response to loading but that lack of Lrp5 activity reduces.... Bone. 2011; 49(2):184-93. PMC: 3121951. DOI: 10.1016/j.bone.2011.03.683. View

Liu Y, Bhat R, Seestaller-Wehr L, Fukayama S, Mangine A, Moran R . The orphan receptor tyrosine kinase Ror2 promotes osteoblast differentiation and enhances ex vivo bone formation. Mol Endocrinol. 2006; 21(2):376-87. DOI: 10.1210/me.2006-0342. View

Ahn Y, Sanderson B, Klein O, Krumlauf R . Inhibition of Wnt signaling by Wise (Sostdc1) and negative feedback from Shh controls tooth number and patterning. Development. 2010; 137(19):3221-31. PMC: 6512258. DOI: 10.1242/dev.054668. View

10.

Korvala J, Juppner H, Makitie O, Sochett E, Schnabel D, Mora S . Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet. 2012; 13:26. PMC: 3374890. DOI: 10.1186/1471-2350-13-26. View

11.

Canalis E, Brunet L, Parker K, Zanotti S . Conditional inactivation of noggin in the postnatal skeleton causes osteopenia. Endocrinology. 2012; 153(4):1616-26. PMC: 3320258. DOI: 10.1210/en.2011-1604. View

12.

Gaudio A, Pennisi P, Bratengeier C, Torrisi V, Lindner B, Mangiafico R . Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab. 2010; 95(5):2248-53. DOI: 10.1210/jc.2010-0067. View

13.

Kugimiya F, Kawaguchi H, Ohba S, Kawamura N, Hirata M, Chikuda H . GSK-3beta controls osteogenesis through regulating Runx2 activity. PLoS One. 2007; 2(9):e837. PMC: 1950686. DOI: 10.1371/journal.pone.0000837. View

14.

Luo J, Zhou W, Zhou X, Li D, Weng J, Yi Z . Regulation of bone formation and remodeling by G-protein-coupled receptor 48. Development. 2009; 136(16):2747-56. PMC: 2730404. DOI: 10.1242/dev.033571. View

15.

Estrada K, Styrkarsdottir U, Evangelou E, Hsu Y, Duncan E, Ntzani E . Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012; 44(5):491-501. PMC: 3338864. DOI: 10.1038/ng.2249. View

16.

Berndt T, Craig T, Bowe A, Vassiliadis J, Reczek D, Finnegan R . Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest. 2003; 112(5):785-94. PMC: 182208. DOI: 10.1172/JCI18563. View

17.

Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson B, Hsu Y, Richards J . Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet. 2009; 41(11):1199-206. PMC: 2783489. DOI: 10.1038/ng.446. View

18.

Zebaze R, Ghasem-Zadeh A, Bohte A, Iuliano-Burns S, Mirams M, Price R . Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study. Lancet. 2010; 375(9727):1729-36. DOI: 10.1016/S0140-6736(10)60320-0. View

19.

Baudhuin M, Solban N, Cornwall-Brady M, Sako D, Kawamoto Y, Liharska K . A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. Proc Natl Acad Sci U S A. 2012; 109(30):12207-12. PMC: 3409793. DOI: 10.1073/pnas.1204929109. View

20.

Woods C, Stricker S, Seemann P, Stern R, Cox J, Sherridan E . Mutations in WNT7A cause a range of limb malformations, including Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndrome. Am J Hum Genet. 2006; 79(2):402-8. PMC: 1559483. DOI: 10.1086/506332. View